Latest Global Markets News

Unith Ltd has strengthened its financial footing by securing a $1 million unsecured facility and receiving initial R&D tax refunds from Spain, validating its advanced AI platform and supporting its growth ambitions.

Invion Limited’s partner Hanlim Pharm, backed by South Korea’s government grant, has secured up to A$2 million in non-dilutive funding to advance preclinical studies of HL270 for oesophageal cancer, paving the way for human trials in Australia.

Little Green Pharma welcomes a landmark US Executive Order directing cannabis rescheduling, a move poised to reshape the global medicinal cannabis landscape.

L1 Global Long Short Fund Limited has successfully raised approximately $477 million through a combination of entitlement, shortfall offers, and an institutional placement, positioning itself for expanded investment activity under its global strategy.

Sparc Technologies has achieved a significant commercial milestone with its first sale of ecosparc®, a graphene-based additive for protective coatings, to an Asian coatings company following successful proof-of-concept testing.

Bailador Technology Investments has increased the valuations of its portfolio companies Updoc and PropHero, driving a notable uplift in net tangible assets per share and signaling strong early performance in FY26.

Proteomics International has secured a US patent for its PromarkerEso blood test, a pioneering diagnostic tool for early detection of esophageal adenocarcinoma, marking a critical step toward commercialisation in the world’s largest healthcare market.

Magellan Investment Partners has launched the Magellan Global Opportunities Fund, an actively managed ETF targeting long-term outperformance of the MSCI World Index with a strong ESG focus and reduced management fees.

Magellan Investment Partners has launched the Magellan Global Equities Fund (Currency Hedged), an actively managed ETF listed on the ASX under ticker MHG, targeting a 9% annual return with integrated ESG considerations.

Metals Australia has successfully expanded its Manindi West Vanadium-Titanium-Magnetite (VTM) discovery, confirming mineralisation over a strike length exceeding 1,000 metres and intersecting significant mineralisation in 13 of 14 drill holes. Early metallurgical results show promise for commercially attractive concentrate products, with further assay results pending.

Acusensus Limited has successfully raised $30 million through a placement of 20 million shares at $1.50 each, supported by both existing and new investors. The capital injection aims to fuel business development, product innovation, and operational expansion.

Vection Technologies reports a record quarter-to-date cash intake of approximately $14 million and a robust $50 million forward pipeline, underscoring strong momentum across defence, AI, healthcare, and retail sectors.